|
| 37199442 | International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility. | Am J Surg Pathol | 2024 |
| 37562993 | Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes. | Eur Urol Oncol | 2024 |
| 37558528 | Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools. | Clin Genitourin Cancer | 2024 |
| 37696743 | Limitations of Prostate Biopsy in Detection of Cribriform and Intraductal Prostate Cancer. | Eur Urol Focus | 2024 |
| 37737692 | International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer. | Am J Surg Pathol | 2024 |
| 37936516 | Head-to-head: how many categories for grading urothelial carcinoma? | Histopathology | 2024 |
| 37980689 | Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? | Int Urol Nephrol | 2024 |
| 37288838 | International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Progresses and Challenges. | Am J Surg Pathol | 2024 |
| 37246824 | International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1: Comparison of Bladder Cancer Grading System Performance. | Am J Surg Pathol | 2024 |
| 37382156 | International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. | Am J Surg Pathol | 2024 |
| 36343786 | UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways. | Cancer Lett | 2023 |
| 37694973 | Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. | Cancer Discov | 2023 |
| 37682613 | Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies. | Clin Nucl Med | 2023 |
| 37606994 | Increasing trend of utilising active surveillance for Gleason Score 7â¿¿(3â¿¿+â¿¿4) prostate cancer. | BJU Int | 2023 |
| 37680023 | ABCC2 brush-border expression predicts outcome in papillary renal cell carcinoma: a multi-institutional study of 254 cases. | Histopathology | 2023 |
| 37927179 | Proliferative cribriform prostate cancer: a new opportunity for 'promising' marker KI-67? | Histopathology | 2023 |
| 37813744 | Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)]. | Eur Urol Oncol | 2023 |
| 35466737 | The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis. | Int J Surg Pathol | 2023 |
| 35816346 | Morphologic Pattern, Frequency, and Spatial Distribution of Lymphovascular Invasion Foci in Radical Prostatectomy Specimens. | Int J Surg Pathol | 2023 |
| 37285311 | The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. | J Natl Cancer Inst | 2023 |
| 37117107 | Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. | Eur Urol | 2023 |
| 37284047 | International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members. | Eur Urol Open Sci | 2023 |
| 37211455 | Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study. | Lancet Digit Health | 2023 |
| 37439809 | Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial. | Clin Cancer Res | 2023 |
| 37074425 | Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions. | Eur Radiol | 2023 |
| 37072903 | Renaming Grade Group 1 Prostate "Cancer" From a Pathology Perspective: A Call for Multidisciplinary Discussion. | Adv Anat Pathol | 2023 |
| 37268513 | Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform Disease. | Eur Urol Focus | 2023 |
| 36813559 | Tumour grading: communication is the key. | J Clin Pathol | 2023 |
| 36748180 | Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. | BJU Int | 2023 |
| 36809425 | The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer. | Eur J Nucl Med Mol Imaging | 2023 |
| 36645163 | Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria. | Histopathology | 2023 |
| 36841687 | Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]. | Eur Urol | 2023 |
| 36710133 | Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. | Eur Urol Oncol | 2023 |
| 36670042 | Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. | Eur Urol Oncol | 2023 |
| 36069585 | The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer. | BJU Int | 2023 |
| 36328436 | Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading. | J Clin Pathol | 2023 |
| 32605887 | Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer. | Eur Urol Oncol | 2022 |
| 35803346 | Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection. | Urology | 2022 |
| 35676330 | Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification. | Mod Pathol | 2022 |
| 35507051 | Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy. | Eur Radiol | 2022 |
| 35577750 | T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum. | Eur Urol Focus | 2022 |
| 35758185 | WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. | Histopathology | 2022 |
| 35852425 | Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. | Radiology | 2022 |
| 36309516 | The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors. | Nat Commun | 2022 |
| 36270849 | LOT and HOT ⿦ or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia. | Pathology | 2022 |
| 36083240 | Low-grade prostate cancer should still be labelled cancer. | BJU Int | 2022 |
| 33771477 | International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. | Eur Urol Focus | 2022 |
| 35074179 | The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes. | Pathology | 2022 |
| 34980492 | Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy. | Eur Urol | 2022 |
| 35151601 | Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients. | Clin Genitourin Cancer | 2022 |